On November 15, the Anhui Provincial Respiratory Diseases Annual Meeting and the 2019 Anhui Provincial Respiratory Specialty Quality Control Center Training Conference held by the Respiratory Branch of the Anhui Medical Association and the Respiratory Quality Control Center of the Anhui Health Commission, Anhui Qixiao® ———— The launch conference of Abidol hydrochloride tablets was grandly held.
The winter is here, and a battle against influenza is also quietly started. In order to better prevent and control influenza, CSPC Anhui area actively responded to the call and was honored to invite the Chinese Medical Association Anhui Branch Respiratory Diseases Professor Zhao Hui, member of the Standing Committee of the Chinese Academy of Sciences, and Professor Xu Congjing, member of the Standing Committee of the Anhui Province Tuberculosis Society, chaired the meeting. Professor Chen Yuqing, a member of the National Cancer Society and chairman of the Anhui Respiratory Society, was a speaker. It was full.
Speech by Professor Zhao Hui
Professor Zhao Hui said that influenza is a public health issue of common concern to all human beings, and that the incidence of influenza in China is increasing year by year, but the current anti-flu resistance rate is increasing, so a new drug is urgently needed for influenza Prevention and treatment provides a brand-new option, and Abidol hydrochloride tablets produced by CSPC just break the bottleneck of high drug resistance rates. In addition, Professor Zhao vividly compared Abidol as a layer of shield, which added strong protection to patients with influenza, integrated prevention and treatment, and significant curative effects, expressing his expectations and recognition for Qixiao®.
Afterwards, the participating experts and manager Chen Zipeng stepped on the stage together, picked up the hourglass full of hope, and sprinkled the sand on our way forward. The screen gradually displayed the eight characters of "New Anti-Flu Qiqi ® New Choice", showing momentum Magnificent, passionate venue, also marked a new milestone in the fight against the flu!
Sharing by Professor Chen Yuqing
During the academic conference, Professor Chen Yuqing shared "Combination of prevention and treatment, a long way to go-introduction to the new anti-influenza drug Abidol". Professor Chen explained the prevention and treatment of influenza and Abidol hydrochloride starting from the epidemiology and prevention of influenza. The role in the prevention and treatment of influenza, and data show that Abidol not only has a significant role in treatment and prevention, but also has reliable safety. On November 13, the Health Commission issued the "Influenza diagnosis and treatment program" (2019 Edition) "and" Influenza Training Manual for Medical Staff (2019 Edition) ", both documents have recommended the hemagglutinin inhibitor Abidol, and Abidol has entered the 2019 national health insurance catalog, so everyone clinical Doctors can safely use Abidol in the fight against the flu, allowing Abidol to exert his "power"!
Speech by Professor Xu Congjing
In the end, Professor Xu Congjing said: I firmly believe in the clinical efficacy of Abidol, firmly believe that Abidol will bring surprises to the flu prevention work, and believe in the excellent quality of CSPC drugs. At the same time, I would also like to thank CSPC for bringing a new anti-influenza option to the clinic-hemagglutinin inhibitor abidol hydrochloride tablets, which breaks the limitation of clinical medication and emphasizes that not every abidol can do it Curious, only Qixiao® can work wonders!